Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
about
Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini ReviewActivity of alkaloids on peptic ulcer: what's new?Nitric oxide-modulating agents for gastrointestinal disordersCelecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancerAntisecretory, gastroprotective, antioxidant and anti-Helicobcter pylori activity of zerumbone from Zingiber zerumbet (L.) SmithCelecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women.Aqueous suspension of anise "Pimpinella anisum" protects rats against chemically induced gastric ulcersMesotherapy versus Systemic Therapy in the Treatment of Acute Low Back Pain: A Randomized Trial.Effects of grape seed extract, vitamin C, and vitamin e on ethanol- and aspirin-induced ulcers.Is licofelone, a dual inhibitor of cyclo-oxygenase and 5-lipoxygenase, a promising alternative in anti-inflammatory therapy?Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.Pes Anserine Bursitis in Symptomatic Osteoarthritis Patients: A Mesotherapy Treatment Study.Antagonism of thromboxane receptors by diclofenac and lumiracoxibGreater allergenicity of topical ketoprofen in contact dermatitis confirmed by use.Protective Effects of Ginger against Aspirin-Induced Gastric Ulcers in Rats.Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: pathophysiology and clinical associations.Complementarity of in vitro and in vivo models for the evaluation of gastro-protective effects of pharmacological substances.Expression of pleiotrophin, an important regulator of cell migration, is inhibited in intestinal epithelial cells by treatment with non-steroidal anti-inflammatory drugs.Proanthocyanidin from grape seed extracts protects indomethacin-induced small intestinal mucosal injury.Depolarization and decreased surface expression of K+ channels contribute to NSAID-inhibition of intestinal restitution.Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid Nanoprodrugs.New pyrazole derivative 5-[1-(4-fluorophenyl)-1H-pyrazol-4-yl]-2H-tetrazole: synthesis and assessment of some biological activities.The interplay between NSAIDs and Candida albicans on the gastrointestinal tract of guinea pigs.Influence of ibuprofen addition on the properties of a bioactive bone cement.The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models.Regular ingestion of cinnamomi cortex pulveratus offers gastroprotective activity in mice.Serotonin and histamine mediate gastroprotective effect of fluoxetine against experimentally-induced ulcers in rats.ADMINISTRATION OF H2 BLOCKERS IN NSAID INDUCED GASTROPATHY IN RATS: effect on histopathological changes in gastric, hepatic and renal tissues.Antinociceptive and anti-hyperalgesic effects of bis(4-methylbenzoyl) diselenide in mice: evidence for the mechanism of action.Gastro-protective effect of methanol extract of Vernonia amygdalina (del.) leaf on aspirin-induced gastric ulcer in Wistar rats.Nanoprodrugs of NSAIDs Inhibit the Growth of U87-MG Glioma CellsIn Vivo Models Used for Evaluation of Potential Antigastroduodenal Ulcer Agents
P2860
Q24634894-8090591A-6840-466A-A0EB-939BC4B0946BQ28088550-E66C6133-A952-43D6-B953-2E349C901CA8Q28192955-5A501BD6-2018-43AF-96CE-C3199B85BB93Q28200802-6A2E22E5-D7DB-45AC-8ECF-8814905015AFQ28544881-00F18274-D2B2-4F19-8408-1CF6E22450C2Q33319315-56182DB6-3917-436A-8DE5-86F29412493DQ34099063-5C9EFE08-51B0-4A5F-AA95-10A9F6E78E16Q34186840-6E619AF4-4E6E-4298-A458-BCF072708A65Q35579408-C9CEC5BC-9F48-47B9-B6D3-2B60D7994525Q35641371-0B1BB2C8-F48C-4D9D-8C00-B4D53CAD4724Q35851151-621C7488-3D97-458B-B8D7-89B9FE0A799BQ35910629-68E54441-5C09-4FDB-86D8-2FB20289EDB0Q36358638-528F893C-BA02-447C-AEF4-BFF5C12EFBAEQ36475477-34DA36D0-369C-41B0-BCAF-A6F49BB1844AQ37149133-6C691F84-DFD8-4D09-9BB8-2BCEE6A295EFQ38250401-45D53FD7-FCD0-4D3B-B79C-39C69044B6C2Q39292937-B7B314FE-1EA6-47BB-9D1C-E35B406BEBF4Q39332507-20C79FA2-E4D0-4C99-AF46-895133D3792DQ39595589-19EC14AD-121A-42F3-BCBE-C01B434D040CQ40133487-7824E05D-5E6E-4BFA-BF6A-CE8743933301Q42147447-61B05E60-A3C2-4D6E-8C4E-F3F568839CABQ42808050-CAB30334-919F-4941-BA43-5C8643D356D4Q44590517-DC241CFF-C22E-469B-B8ED-B8534BC97C0CQ45770898-756BC06C-6EDE-4FB7-817B-4D73212FC820Q46351150-F5D47BA7-D9C8-4E9F-B5B3-A3563A2887FDQ46468050-D9C0F014-24E8-48DC-812F-1A1F5C4E7CAAQ46564442-47FDCBCB-FA5A-4390-ABDE-A5281BAD7FDFQ53086436-614E26D9-4947-490A-A5D4-75EAFB0D2D0BQ53666895-6AC27A40-0A86-4B07-AA82-C078B3A08DCBQ55021584-8B4DB4EF-89E5-4614-83B4-C747B1CD1666Q58652161-B9D9F28E-7FD6-43FB-B78D-14910B5EFF9EQ58920132-C80BD18B-EF2E-45C7-A476-086EBCA43E9A
P2860
Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
@ast
Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
@en
type
label
Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
@ast
Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
@en
prefLabel
Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
@ast
Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
@en
P2860
P1476
Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
@en
P2093
Brendan J R Whittle
P2860
P304
P356
10.1046/J.1472-8206.2003.00135.X
P577
2003-06-01T00:00:00Z